8/19/2019 GNIPST Bulletin 53.4
1/27
mailto:[email protected]://plus.google.com/u/0/photos/111714720327580099858/albums/5897323676427099873?sort=7
8/19/2019 GNIPST Bulletin 53.4
2/27
8/19/2019 GNIPST Bulletin 53.4
3/27
8/19/2019 GNIPST Bulletin 53.4
4/27
http://www.famousscientists.org/max-planck/
8/19/2019 GNIPST Bulletin 53.4
5/27
8/19/2019 GNIPST Bulletin 53.4
6/27
mailto:[email protected]
8/19/2019 GNIPST Bulletin 53.4
7/27
8/19/2019 GNIPST Bulletin 53.4
8/27
http://www.drugs.com/newdrugs/fda-approves-bayer-s-kovaltry-antihemophilic-factor-recombinant-children-adults-hemophilia-4357.htmlhttp://d/Jeenat/Bulletin%2034.3_1/New%20Folder/UPCOMING%20EVENTS.docxhttp://www.who.int/csr/don/14-march-2016-chikungunya-argentina/en/
8/19/2019 GNIPST Bulletin 53.4
9/27
8/19/2019 GNIPST Bulletin 53.4
10/27
8/19/2019 GNIPST Bulletin 53.4
11/27
8/19/2019 GNIPST Bulletin 53.4
12/27
8/19/2019 GNIPST Bulletin 53.4
13/27
8/19/2019 GNIPST Bulletin 53.4
14/27
8/19/2019 GNIPST Bulletin 53.4
15/27
8/19/2019 GNIPST Bulletin 53.4
16/27
8/19/2019 GNIPST Bulletin 53.4
17/27
8/19/2019 GNIPST Bulletin 53.4
18/27
8/19/2019 GNIPST Bulletin 53.4
19/27
8/19/2019 GNIPST Bulletin 53.4
20/27
8/19/2019 GNIPST Bulletin 53.4
21/27
8/19/2019 GNIPST Bulletin 53.4
22/27
8/19/2019 GNIPST Bulletin 53.4
23/27
mailto:[email protected]
8/19/2019 GNIPST Bulletin 53.4
24/27
8/19/2019 GNIPST Bulletin 53.4
25/27
8/19/2019 GNIPST Bulletin 53.4
26/27
8/19/2019 GNIPST Bulletin 53.4
27/27